Apollo Commercial Real Estate Finance Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw a major loan portfolio sale, boosting cash and book value, with management focused on strategic alternatives and capital preservation. Dividend policy targets an 8% yield, and share repurchases have accreted book value. Updates on future strategy are expected soon.
-
A definitive agreement was reached to sell the loan portfolio for 99.7% of commitments, unlocking $1.4 billion in cash and validating book value. The transaction provides a 23% premium to recent trading levels, supports continued dividends, and initiates a strategic review for new opportunities.
Fiscal Year 2025
-
Announced sale of the loan portfolio to Athene, with focus on maximizing value from four retained REO assets. Q4 distributable earnings were $37M, and the loan portfolio grew to $8.8B. Dividend for Q1 2025 is expected at $0.25 per share, with future strategy and distributions under review.
-
Q3 2025 saw strong loan origination and repayments, with $1 billion in new loans and $48 million in GAAP net income. Focus asset sales and robust liquidity position the portfolio for growth, while capital redeployment and sector diversification are expected to drive earnings in 2026.
-
Q2 2025 saw strong loan originations, portfolio growth to $8.6B, and robust earnings, with capital rotation from focused assets expected to drive further gains. Refinancing extended debt maturities, and liquidity was enhanced by new credit facilities.
-
Q1 saw robust loan origination and portfolio growth despite increased market volatility and recessionary concerns. Distributable earnings covered 96% of the dividend, with higher earnings expected for the rest of 2025. Leverage and liquidity remain strong, and capital deployment will be funded by repayments and asset resolutions.
Fiscal Year 2024
-
Robust loan origination and repayments marked 2024, with a diversified portfolio and strong liquidity. Earnings are expected to dip in 2025 due to rate cuts, but dividend coverage remains solid. Portfolio growth is anticipated as capital is redeployed from repayments.
-
Improved market conditions and robust loan repayments enabled significant new loan commitments and proactive asset management. A major realized loss on a Massachusetts hospital loan impacted GAAP results, but strong liquidity and ongoing portfolio repositioning support future earnings growth.
-
Q2 2024 saw stable earnings, robust loan repayments, and active capital redeployment, with a strong pipeline for new investments. A $90 million CECL allowance is anticipated for a hospital loan due to Steward's bankruptcy, while portfolio and dividend outlooks remain steady.